Johan Van Hoof

in page functions

Managing Director of Crucell

Johan van Hoof

Johan Van Hoof is Managing Director of Crucell. Formerly, he was Global Therapeutic Area Head, Infectious Diseases & Vaccines, Pharmaceuticals Research & Development, Johnson & Johnson. From November 2007 through March 2010, Dr Van Hoof was Chief Operating Officer - Head, Global Development Organization, JnJ Pharmaceuticals Research & Development. Prior to November 2007, he was Vice President of Global Clinical Operations.

Before joining J&J, Mr. Van Hoof acquired more than 20 years of experience in the vaccine industry, having worked with Pasteur Mérieux Connaught (today Sanofi Aventis), Chiron Vaccines and GlaxoSmithKline (GSK) Biologicals. During this period, he held leadership roles with increasing responsibilities covering, clinical development, QA- QC, and regulatory affairs. He was actively involved in the development and licensing of a new generation of childhood and adult vaccines in disease areas such as pertussis, meningitis, rotaviral diarrhea, hepatitis, flu and HPV.  

+4 million

Gavi support had contributed to immunising more than four million children against rotavirus diarrhoea by the end of 2013.

WHO/UNICEF

More facts...

close icon

modal window here